Patent Assignment
Reel/Frame 062568/0055
Dissolution of Celltech R&D, Inc. and Subsequent Distribution of Assests into Darwin Molecular Corporation
Recorded: 2023-01-31
Pages: 8
Assignor
CELLTECH R&D, INC.
Executed: 2004-12-28
Assignee
DARWIN MOLECULAR CORPORATION
1631 220TH STREET S.E., BOTHELL, WASHINGTON, 98201
Covered Property
(1)
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Jan 31, 2023
From: DARWIN MOLECULAR CORPORATION
To: UCB MANUFACTURING, INC.
Reel/Frame 062543/0509 →
Assignment of Assignor's Interest
Jan 31, 2023
From: WINKLER, DAVID G.; SHI, JIYE; LATHAM, JOHN
To: CELLTECH R&D, INC.
Reel/Frame 062543/0556 →
Assignment of Assignor's Interest
Jan 31, 2023
From: UCB MANUFACTURING, INC.
To: UCB PHARMA S.A.
Reel/Frame 062543/0748 →